Table of Contents Author Guidelines Submit a Manuscript
Obstetrics and Gynecology International
Volume 2013, Article ID 752980, 7 pages
http://dx.doi.org/10.1155/2013/752980
Research Article

The Leading Concerns of American Women with Nausea and Vomiting of Pregnancy Calling Motherisk NVP Helpline

The Motherisk Program, Division of Clinical Pharmacology/Toxicology, The Hospital for Sick Children, The University of Toronto, 555 University Avenue, Toronto, ON, Canada M5G 1X8

Received 4 February 2013; Accepted 15 March 2013

Academic Editor: Gian Carlo Di Renzo

Copyright © 2013 Svetlana Madjunkova et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Koren, C. Maltepe, and R. Gow, “Therapeutic choices for nausea and vomiting of pregnancy: a critical review of a systematic review,” Journal of Obstetrics and Gynaecology Canada, vol. 33, no. 7, pp. 733–735, 2011. View at Google Scholar
  2. C. I. Neutel and H. L. Johansen, “Measuring drug effectiveness by default: the case of bendectin,” Canadian Journal of Public Health, vol. 86, no. 1, pp. 66–70, 1995. View at Google Scholar · View at Scopus
  3. A. Einarson, C. Maltepe, R. Boskovic, and G. Koren, “Treatment of nausea and vomiting in pregnancy: an updated algorithm,” Canadian Family Physician, vol. 53, no. 12, pp. 2109–2111, 2007. View at Google Scholar · View at Scopus
  4. P. Mazzotta, L. A. Magee, C. Maltepe, A. Lifshitz, Y. Navioz, and G. Koren, “The perception of teratogenic risk by women with nausea and vomiting of pregnancy,” Reproductive Toxicology, vol. 13, no. 4, pp. 313–319, 1999. View at Publisher · View at Google Scholar · View at Scopus
  5. N. Ebrahimi, C. Maltepe, F. G. Bournissen, and G. Koren, “Nausea and vomiting of pregnancy: using the 24-hour Pregnancy-Unique Quantification of Emesis (PUQE-24) scale,” Journal of Obstetrics and Gynaecology Canada, vol. 31, no. 9, pp. 803–807, 2009. View at Google Scholar · View at Scopus
  6. A. Shrim, R. Boskovic, C. Maltepe, Y. Navios, F. Garcia-Bournissen, and G. Koren, “Pregnancy outcome following use of large doses of vitamin B6 in the first trimester,” Journal of Obstetrics and Gynaecology, vol. 26, no. 8, pp. 749–751, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Maltepe, R. Gow, and G. Koren, “Updated guidelines for the management of nausea and vomiting of pregnancy and hyperemesis gravidarum,” in Clinical Pharmacology During Pregnancy, D. R. Mattison, Ed., pp. 157–171, Elsevier, Waltham, Mass, USA, 1st edition, 2013. View at Google Scholar
  8. M. Anderka, A. A. Mitchell, C. Louik et al., “Medications used to treat nausea and vomiting of pregnancy and the risk of selected birth defects,” Birth Defects Research A: Clinical and Molecular Teratology, vol. 94, no. 1, pp. 22–30, 2012. View at Publisher · View at Google Scholar
  9. http://www.fda.gov/Drugs/DrugSafety/ucm271913.htm.
  10. T. Hale, Doxylamine. Medications and Mothers’ Milk. A Manual of Lactation Pharmacology, Hale Publishing, Amarilo, Tex, USA, 2012.
  11. T. Hale, Pyridoxine. Medications and Mothers’ Milk. A Manual of Lactation Pharmacology, Hale Publishing, Amarilo, Tex, USA, 2012.
  12. G. Koren, “Motherisk update. Is ondansetron safe for use during pregnancy?” Canadian Family Physician, vol. 58, no. 10, pp. 1092–1093, 2012. View at Google Scholar